This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ZY Zymergen (ZY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Zymergen Stock (NASDAQ:ZY) 30 days 90 days 365 days Advanced Chart Remove Ads Get Zymergen alerts:Sign Up Key Stats Today's Range$2.43▼$2.4350-Day Range$2.35▼$3.1452-Week Range$1.10▼$12.42Volume85 shsAverage Volume1.23 million shsMarket Capitalization$253.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewZymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.Read More… Remove Ads Receive ZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zymergen and its competitors with MarketBeat's FREE daily newsletter. Email Address ZY Stock News HeadlinesThe California crisis in homeowners insurance has only one real solutionMarch 10, 2025 | msn.comHere's how much Sutter Health just spent on its new 12-acre campus in EmeryvilleFebruary 21, 2025 | bizjournals.comTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.April 4, 2025 | Crypto 101 Media (Ad)Advanced Materials (AdMs) in Defense Thematic Intelligence Research ReportSeptember 18, 2024 | finance.yahoo.comSEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales ProspectsSeptember 13, 2024 | msn.comOhmium Announces Enakshi Singh as New Chief Financial OfficerAugust 27, 2024 | sg.finance.yahoo.comGinkgo Bioworks Holdings, Inc. (DNA) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comGinkgo Bioworks: Broken NarrativeMay 10, 2024 | seekingalpha.comSee More Headlines ZY Stock Analysis - Frequently Asked Questions When did Zymergen IPO? Zymergen (ZY) raised $401 million in an initial public offering (IPO) on Thursday, April 22nd 2021. The company issued 13,600,000 shares at $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard served as the underwriters for the IPO. What other stocks do shareholders of Zymergen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zymergen investors own include Tesla (TSLA), NIO (NIO), Meta Platforms (META), PayPal (PYPL), Snowflake (SNOW) and Teladoc Health (TDOC). Company Calendar Today4/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBasic Materials Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:ZY CIK1645842 Webwww.zymergen.com Phone415-801-8073FaxN/AEmployees502Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-361,790,000.00 Net Margins-2,508.94% Pretax Margin-2,508.42% Return on Equity-93.37% Return on Assets-61.14% Debt Debt-to-Equity RatioN/A Current Ratio4.59 Quick Ratio4.47 Sales & Book Value Annual Sales$16.74 million Price / Sales15.15 Cash FlowN/A Price / Cash FlowN/A Book Value$3.99 per share Price / Book0.61Miscellaneous Outstanding Shares104,355,000Free Float92,145,000Market Cap$253.58 million OptionableNot Optionable Beta1.69 Social Links Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (NASDAQ:ZY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zymergen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zymergen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.